m.Stock by Mirae AssetOpen Demat Account
m.Stock by Mirae Asset

IPOCuris Lifesciences Ltd IPO

  • Price Range

    ₹120 - ₹128

  • Min. Quantity

    2,000 Shares

  • Closes on

    11 November 2025

  • Min. investment

    ₹2,56,000

Curis Lifesciences Ltd IPO Timeline

EventDate
Curis Lifesciences Ltd IPO Opening Date7 November 2025
Curis Lifesciences Ltd IPO Closing Date 11 November 2025
Basis of Allotment12 November 2025
Initiation of Refunds13 November 2025
Credit of Shares to Demat13 November 2025
Curis Lifesciences Ltd IPO Listing Date14 November 2025

Curis Lifesciences Ltd IPO Details

Curis Lifesciences Ltd IPO Date7 November 2025 to 11 November 2025
Curis Lifesciences Ltd IPO Face Value₹10 per share
Curis Lifesciences Ltd IPO Price₹120 to ₹128 per share
Curis Lifesciences Ltd IPO Lot Size2,000
Issue Size Shares of ₹10 (aggregating up to ₹27.52 Cr)
Fresh Issue Shares of ₹10 (aggregating up to ₹27.52 Cr)
Offer for Sale-
Issue TypeBook Building - SME
Listing At NSE - SME
QIB Shares OfferedNot more than 4,08,000 of the Net Offer
Retail Shares OfferedNot less than 7,16,000 of the Net Offer
NII (HNI) Shares OfferedNot less than 4,16,000 of the Net Offer
Company PromotersDharmesh Dashrathbhai Patel, Siddhant Jayantibhai Pawasia, Piyush Gordhanbhai Antala

Curis Lifesciences Ltd IPO Lot Size

The Curis Lifesciences Ltd IPO lot size is 2,000 shares. A retail-individual investor can apply for up to 0 lots (0 shares or ₹0).

Application LotsSharesAmount
Minimum12,000₹2,56,000
Maximum-0₹0
  • Risks
  • Opportunities
  • Experienced Promoters and Management Team.
  • Wide range of Products.
  • Strategic Location of Manufacturing Facility.
  • Scalable Business Model.
  • Quality assurance.

Company Financials

Curis Lifesciences Ltd Financial Information (Restated)

Period Ended Total AssetsTotal RevenueProfit After Tax
03-202542.5349.656.11
03-202433.8235.895.36
03-202329.6735.761.23
Amount in ₹ Crore

Objects of the Issue

The company proposes to utilise the Net Proceeds from the Fresh Issue towards funding the following objects:

  • Funding capital expenditure towards improvement of its existing mfg facility at
  • Repayment of secured loans outstanding in the name of company
  • Products registrations in other countries
  • Funding its working capital requirements
  • General corporate purposes

Curis Lifesciences Ltd IPO Promoter Holding

Pre Issue Share Holding18.07%
Post Issue Share Holding13.27%

Curis Lifesciences Ltd IPO Subscription Status (Bidding Detail)

The Curis Lifesciences Ltd IPO is subscribed 69.2485 times on 11 November 2025 05:00:00 PM. The public issue subscribed 44.2821 times in the retail category, 96.4093 times in the QIB category, and 85.7476 times in the NII category. Check Day by Day Subscription Details (Live Status)

CategoryQIBNIIRetailEmployeeTotal
Subscription (times)96.409385.747644.2821-69.2485

Curis Lifesciences Ltd IPO Prospectus

Curis Lifesciences Ltd IPO Listing Date

BSE Script
NSE Symbol
Listing In NSE - SME
ISININE1BZN01016
IPO Price₹-
Face Value-

Company Contact Information

Curis Lifesciences Ltd
PF-23 GIDC Sanand IIIndustrial Estate,Ahmedabad-382110
Phone: +91 70965 58558
Email: info@curisls.com
Website: https://curisls.com

Curis Lifesciences Ltd IPO Registrar

Curis Lifesciences Ltd IPO Lead Manager(s)

  1. Finaax Capital Advisors Private Limited

How to Check the Allotment Status of Curis Lifesciences Ltd IPO?

To check the IPO allotment status, follow these steps:

  • Visit the official website of the IPO registrar.
  • Navigate to the IPO Allotment Status page.
  • Select “Curis Lifesciences Ltd” from the list of available IPOs.
  • Enter any one of these - PAN Number, Application Number, DP/Client ID.
  • Click on Submit to view your allotment status.
  • Alternatively, you can also check the allotment status on the stock exchange websites such as NSE or BSE.
  • About Curis Lifesciences Ltd IPO

    Curis Lifesciences Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name and style of 'M/s Loreto Pharmaceutacals', pursuant to a Deed of Partnership dated 2 June, 2010. Thereafter ' M/s Loreto Pharmaceutacals' was converted from Partnership Firm to a Private Limited Company as 'Curis Lifesciences Private Limited' and received a Certificate of Incorporation dated on March 23rd, 2016 issued by Registrar of Companies, Ahmedabad. Subsequently, Company was converted into a Public Limited Company and the name of the Company was changed from 'Curis Lifesciences Private Limited' to 'Curis Lifesciences Limited' vide certified incorporated upon the conversion dated August 9, 2024, issued by the Central Processing Centre, Manesar.

    FAQ